[논문]Bispecific antibody drug conjugates: Making 1+1>2

                                                           Yilin Gu, Zhijia Wang, Yuxi Wang​ I Acta Pharmaceutica Sinica B

Bispecific antibody‒drug conjugates (BsADCs) combine the strengths of ADCs and BsAbs.

BsADC could be positioned as the next-generation ADC approach.Challenges are poor internalization, off-target toxicity, and drug resistance.

​